Lucid Diagnostics Stock Market Value
| LUCD Stock | USD 0.84 0.01 1.18% |
| Symbol | Lucid |
Lucid Diagnostics Price To Book Ratio
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lucid Diagnostics. If investors know Lucid will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lucid Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.12) | Revenue Per Share | Quarterly Revenue Growth 0.497 | Return On Assets | Return On Equity |
The market value of Lucid Diagnostics is measured differently than its book value, which is the value of Lucid that is recorded on the company's balance sheet. Investors also form their own opinion of Lucid Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Lucid Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lucid Diagnostics' market value can be influenced by many factors that don't directly affect Lucid Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lucid Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Lucid Diagnostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lucid Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Lucid Diagnostics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Lucid Diagnostics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Lucid Diagnostics.
| 12/19/2024 |
| 01/18/2025 |
If you would invest 0.00 in Lucid Diagnostics on December 19, 2024 and sell it all today you would earn a total of 0.00 from holding Lucid Diagnostics or generate 0.0% return on investment in Lucid Diagnostics over 30 days. Lucid Diagnostics is related to or competes with Inari Medical, Beyond Air, Clearpoint Neuro, LivaNova PLC, Electromed, Orthopediatrics Corp, and SurModics. Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company More
Lucid Diagnostics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Lucid Diagnostics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Lucid Diagnostics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.47 | |||
| Information Ratio | 0.0414 | |||
| Maximum Drawdown | 16.11 | |||
| Value At Risk | (4.44) | |||
| Potential Upside | 5.88 |
Lucid Diagnostics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Lucid Diagnostics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Lucid Diagnostics' standard deviation. In reality, there are many statistical measures that can use Lucid Diagnostics historical prices to predict the future Lucid Diagnostics' volatility.| Risk Adjusted Performance | 0.0497 | |||
| Jensen Alpha | 0.1455 | |||
| Total Risk Alpha | 0.0772 | |||
| Sortino Ratio | 0.0385 | |||
| Treynor Ratio | 0.3924 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Lucid Diagnostics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Lucid Diagnostics Backtested Returns
At this point, Lucid Diagnostics is very risky. Lucid Diagnostics has Sharpe Ratio of 0.016, which conveys that the firm had a 0.016% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Lucid Diagnostics, which you can use to evaluate the volatility of the firm. Please verify Lucid Diagnostics' Downside Deviation of 3.47, risk adjusted performance of 0.0497, and Mean Deviation of 2.47 to check out if the risk estimate we provide is consistent with the expected return of 0.0524%. Lucid Diagnostics has a performance score of 1 on a scale of 0 to 100. The company secures a Beta (Market Risk) of 0.39, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, Lucid Diagnostics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Lucid Diagnostics is expected to be smaller as well. Lucid Diagnostics right now secures a risk of 3.28%. Please verify Lucid Diagnostics maximum drawdown, skewness, and the relationship between the total risk alpha and downside variance , to decide if Lucid Diagnostics will be following its current price movements.
Auto-correlation | -0.22 |
Weak reverse predictability
Lucid Diagnostics has weak reverse predictability. Overlapping area represents the amount of predictability between Lucid Diagnostics time series from 19th of December 2024 to 3rd of January 2025 and 3rd of January 2025 to 18th of January 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Lucid Diagnostics price movement. The serial correlation of -0.22 indicates that over 22.0% of current Lucid Diagnostics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.22 | |
| Spearman Rank Test | 0.2 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Lucid Diagnostics lagged returns against current returns
Autocorrelation, which is Lucid Diagnostics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Lucid Diagnostics' stock expected returns. We can calculate the autocorrelation of Lucid Diagnostics returns to help us make a trade decision. For example, suppose you find that Lucid Diagnostics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Lucid Diagnostics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Lucid Diagnostics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Lucid Diagnostics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Lucid Diagnostics stock over time.
Current vs Lagged Prices |
| Timeline |
Lucid Diagnostics Lagged Returns
When evaluating Lucid Diagnostics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Lucid Diagnostics stock have on its future price. Lucid Diagnostics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Lucid Diagnostics autocorrelation shows the relationship between Lucid Diagnostics stock current value and its past values and can show if there is a momentum factor associated with investing in Lucid Diagnostics.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin |
Check out Lucid Diagnostics Correlation, Lucid Diagnostics Volatility and Lucid Diagnostics Alpha and Beta module to complement your research on Lucid Diagnostics. For information on how to trade Lucid Stock refer to our How to Trade Lucid Stock guide.You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Lucid Diagnostics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.